WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Melt-irradiated ultra high molecular weight polyethylene prosthetic devices    
United States Patent5879400   
Link to this pagehttp://www.wikipatents.com/5879400.html
Inventor(s)Merrill; Edward W. (Belmont, MA); Harris; William H. (Belmont, MA); Venugopalan; Premnath (Cambridge, MA); Jasty; Murali (Weston, MA); Bragdon; Charles R. (Weymouth, MA); O'Connor; Daniel O. (East Taunton, MA)
AbstractA medical prosthesis for use within the body which is formed of ultra high molecular weight polyethylene which has a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus, so as to reduce production of fine particles from the prosthesis during wear of the prosthesis, is described. Methods of manufacture of such devices and material used therein are also provided.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Inventor     Merrill; Edward W. (Belmont, MA); Harris; William H. (Belmont, MA); Venugopalan; Premnath (Cambridge, MA); Jasty; Murali (Weston, MA); Bragdon; Charles R. (Weymouth, MA); O'Connor; Daniel O. (East Taunton, MA)
Owner/Assignee     Massachusetts Institute of Technology (Cambridge, MA); The General Hospital Corporation (Boston, MA)
Patent assignment
All assignments
Publication Date     March 9, 1999
Application Number     08/600,744
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     February 13, 1996
US Classification     623/22.11 526/352
Int'l Classification     A61F 002/34
Examiner     Weiss; John G.
Assistant Examiner     Cuddihy; Francis K.
Attorney/Law Firm     Greer; Helen Banner & Witcoff, Ltd.
Address
Parent Case    
Priority Data    
USPTO Field of Search     623/18 623/19 623/20 623/22 623/21 623/23 526/352 427/2.26 427/525 427/527
Patent Tags     melt-irradiated ultra high molecular weight polyethylene prosthetic devices
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
3297641



[0 after 0 votes]
3352818



[0 after 0 votes]
3758273



[0 after 0 votes]
5593719
Dearnaley
427/2.26
Jan,1997

[0 after 0 votes]
5549700
Graham
623/22.14
Aug,1996

[0 after 0 votes]
5549698
Averill
623/22.22
Aug,1996

[0 after 0 votes]
5543471
Sun
525/333.7
Aug,1996

[0 after 0 votes]
5515590
Pienkowski
29/404
May,1996

[0 after 0 votes]
5480683
Chabrol
427/525
Jan,1996

[0 after 0 votes]
5478906
Howard, Jr.
526/352
Dec,1995

[0 after 0 votes]
5466530
England
428/411.1
Nov,1995

[0 after 0 votes]
5449745
Sun
528/483
Sep,1995

[0 after 0 votes]
5414049
Sun
525/333.7
May,1995

[0 after 0 votes]
5407623
Zachariades
264/119
Apr,1995

[0 after 0 votes]
5160472
Zachariades

Nov,1992

[0 after 0 votes]
5160464
Ward

Nov,1992

[0 after 0 votes]
5037928
Li
526/352
Aug,1991

[0 after 0 votes]
5024670
Smith
128/898
Jun,1991

[0 after 0 votes]
4944974
Zachariades
428/36.1
Jul,1990

[0 after 0 votes]
4747990
Gaussens
264/322
May,1988

[0 after 0 votes]
4655769
Zachariades
623/1.49
Apr,1987

[0 after 0 votes]
3944536
Lupton
526/352
Mar,1976

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. A medical prosthesis for use within a body,

said prosthesis being formed of cross-linked ultra high molecular weight polyethylene having a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus, so as to reduce production of fine particles from said-prosthesis during wear of said prosthesis.

2. The prosthesis of claim 1 wherein said ultra high molecular weight polyethylene has substantially no trapped free radicals.

3. The prosthesis of claim 1 wherein said ultra high molecular weight polyethylene has a Shore D scale hardness of less than about 65.

4. The prosthesis of claim 1 wherein said ultra high molecular weight polyethylene is substantially not oxidized.

5. The prosthesis of claim 1 wherein said ultra high molecular weight polyethylene has substantially no chain scission.

6. The prosthesis of claim 1 wherein said polymeric structure has extensive cross-linking so that a substantial portion of said polymeric structure does not dissolve in decahydronaphthalene at 150.degree. C. over a period of 24 hours.

7. The prosthesis of claim 1 wherein said ultra high molecular weight polyethylene has a high density of entanglement so as to cause formation of imperfect crystals and reduce crystallinity.

8. The prosthesis of claim 1 wherein said ultra high molecular weight polyethylene has an initial average molecular weight of greater than about 2 million.

9. The prosthesis of claim 1 wherein said ultra high molecular weight polyethylene has a polymeric structure with about 40% crystallinity, about 100 .ANG. lamellar thickness and about 200 MPa tensile elastic modulus.

10. The prosthesis of claim 1 wherein part of said prosthesis is in a form of a cup shaped article having a load bearing surface.

11. The prosthesis of claim 10 wherein said load bearing surface is in contact with a second part of said prosthesis having a mating load bearing surface of a metallic or ceramic material.

12. The prosthesis of claim 1 wherein said prosthesis is constructed and arranged for hip or knee joint replacement.

13. Cross-linked ultra high molecular weight polyethylene having a polymeric structure characterized by less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus.

14. The ultra high molecular weight polyethylene of claim 13 wherein said ultra high molecular weight polyethylene has high transmissivity of light.

15. The ultra high molecular weight polyethylene of claim 13 wherein said ultra high molecular weight polyethylene is a film or sheet, said film or sheet being transparent and wear resistant.

16. A fabricated article formed of cross-linked ultra high molecular weight poplyethylene having a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus.

17. The fabricated article of claim 16 wherein said fabricated article is in a form of a bar stock capable of being shaped into a second article by machining.

18. The fabricated article of claim 16 wherein said fabricated article has a load bearing surface.

19. A method of making a prosthesis from cross-linked ultra high molecular weight polyethylene so as to reduce production of fine particles from the prosthesis during wear of the prosthesis, comprising the steps of:

providing cross-linked ultra high molecular weight polyethylene having a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus; and

forming a prosthesis from said ultra high molecular weight polyethylene so as to reduce production of fine particles from said prosthesis during wear of said prosthesis,

said ultra high molecular weight polyethylene forming a load bearing surface of said prosthesis.

20. A method of treating a body in need of a prosthesis, comprising:

providing a shaped prosthesis formed of cross-linked ultra high molecular weight polyethylene having a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus; and

applying said prosthesis to said body in need of said prosthesis.
 Description Submit all comments and votes
 


FIELD OF THE INVENTION

The present invention relates to the orthopedic field and the provision of prostheses, such as hip and knee implants, as well as methods of manufacture of such devices and material used therein.

BACKGROUND OF THE INVENTION

The use of synthetic polymers, e.g., ultra high molecular weight polyethylene, with metallic alloys has revolutionized the field of prosthetic implants, e.g., their use in total joint replacements for the hip or knee. Wear of the synthetic polymer against the metal of the articulation, however, can result in severe adverse effects which predominantly manifest after several years. Various studies have concluded that such wear can lead to the liberation of ultrafine particles of polyethylene into the periprosthetic tissues. It has been suggested that the abrasion stretches the chain folded crystallites to form anisotropic fibrillar structures at the articulating surface. The stretched-out fibrils can then rupture, leading to production of submicron sized particles. In response to the progressive ingress of these polyethylene particles between the prosthesis and bone, macrophage-induced resorption of the periprosthetic bone is initiated. The macrophage, often being unable to digest these polyethylene particles, synthesize and release large numbers of cytokines and growth factors which can ultimately result in bone resorption by osteoclasts and monocytes. This osteolysis can contribute to mechanical loosening of the prosthesis components, thereby sometimes requiring revision surgery with its concomitant problems.

SUMMARY OF THE INVENTION

It is an object of the invention to provide an implantable prosthesis device formed at least in part of melt-irradiated ultra high molecular weight polyethylene (UHMWPE) which results in reduced production of fine particles from the prosthesis during wear of the prosthesis.

It is another object of the invention to reduce osteolysis and inflammatory reactions resulting from prosthesis implants.

It is yet another object of the invention to provide a prosthesis which can remain implanted within a person for prolonged periods of time.

It is yet another object of the invention to provide improved UHMWPE which can be used in the prostheses of the preceding objects.

Still another object of the invention is to provide improved UHMWPE which has a highly entangled and low crystalline polymeric structure.

A still further object of the invention is to provide improved UHMWPE which is relatively transparent and wear resistant.

According to the invention, a medical prosthesis for use within the body, e.g., for hip or knee joint replacement, is provided. It is formed at least in part of an UHMWPE which has a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus, so as to reduce production of fine particles from the prosthesis during wear of the prosthesis. In one embodiment the UHMWPE has a polymeric structure with about 40% crystallinity, about 100 .ANG. lamellar thickness and about 200 MPa tensile elastic modulus. Preferably, the UHMWPE has substantially no trapped free radicals, has reduced hardness, is substantially not oxidized, has substantially no chain scission, has extensive cross-linking so that a substantial portion of the polymeric structure does not dissolve in Decalin.TM. (decahydronaphthalene) at 150.degree. C. over a period of 24 hours, and/or has a high density of entanglement so as to cause the formation of imperfect crystals and reduce crystallinity. The UHMWPE initially has a molecular weight greater than about 500,000, preferably greater than about 1,000,000 and more preferably greater than about 2,000,000. In certain embodiments, part of the prosthesis is in the form of a cup shaped article having a load bearing surface made of this UHMWPE. This load bearing surface can be in contact with a second part of the prosthesis having a mating load bearing surface of a metallic or ceramic material.

Another aspect of the invention is UHMWPE having a unique polymeric structure characterized by less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus. The UHMWPE can also have high transmissivity of light.

Yet other aspects of the invention are fabricated articles, e.g., with a load bearing surface, and transparent and wear resistant coatings, made from such UHMWPE. One embodiment is where the fabricated article is in the form of a bar stock which is capable of being shaped into articles by conventional methods, e.g., machining.

Yet another aspect of the invention includes a method for making highly entangled and crosslinked UHMWPE. Conventional UHMWPE, in the form of, e.g., a powder, a bar stock, a shaped bar stock, a coating or a fabricated article, e.g., a cup shaped article for use in a prosthesis, is provided. Preferably, the UHMWPE starting material has an average molecular weight of greater than about 2 million. The UHMWPE is surrounded with an inert material that is substantially free of oxygen. The UHMWPE is heated at or above its melting temperature, preferably, at about 145.degree. C. to about 230.degree. C., more preferably at about 175.degree. C. to about 200.degree. C., for a time sufficient to allow the polymer chains to achieve an entangled state, e.g., for a period of about 5 minutes to about 3 hours. The heated UHMWPE is then crosslinked so as to trap the polymer chains in the entangled state using irradiation, e.g., with gamma irradiation or electron irradiation, preferably allowing a dose greater than about 1 MRad, more preferably a dose greater than about 20 MRad. The irradiated UHMWPE is then cooled to about 25.degree. C., preferably at a rate equal to or greater than about 0.5.degree. C./min., more preferably at a rate equal to or greater than about 120.degree. C./min. In certain embodiments, the cooled UHMWPE is then machined or compression molded.

Yet another aspect of the invention includes the product made in accordance with this method.

The invention also features a method of making a prosthesis from UHMWPE so as to reduce production of fine particles from the prosthesis during wear of the prosthesis. UHMWPE having a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus is provided. A prosthesis is formed from this UHMWPE, the UHMWPE forming a load bearing surface of the prosthesis.

Yet another aspect of the invention includes a method of treating a body in need of a prosthesis. A shaped prosthesis formed of ultra high molecular weight polyethylene having a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus, is provided. This prosthesis is applied to the body in need of the prosthesis.

The above and other objects, features and advantages of the present invention will be better understood from the following specification when read in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a cross-sectional view through the center of a medical hip joint prosthesis in accordance with a preferred embodiment of this invention;

FIG. 2 is a side view of an acetabular cup liner as shown in FIG. 1;

FIG. 3 is a cross-sectional view through line 3--3 of FIG. 2;

FIG. 4 is a graph showing the crystallinity and melting point of melt-irradiated UHMWPE at different irradiation doses;

FIG. 5 is an environmental scanning electron micrograph of an etched surface of conventional UHMWPE showing its crystalline structure;

FIG. 6 is an environmental scanning electron micrograph of an etched surface of melt-irradiated UHMWPE showing its crystalline structure at approximately the same magnification as in FIG. 5; and

FIG. 7 is a graph showing the crystallinity and melting point at different depths of a melt-irradiated UHMWPE cup.

DETAILED DESCRIPTION

This invention provides a medical prosthesis for use within the body which is formed of ultra high molecular weight polyethylene (UHMWPE) which has a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus, so as to reduce production of fine particles from the prosthesis during wear of the prosthesis.

A medical prosthesis in the form of a hip joint prosthesis is generally illustrated at 10 in FIG. 1. The prosthesis shown has a conventional ball head 14 connected by a neck portion to a stem 15 which is mounted by conventional cement 17 to the femur 16. The ball head can be of conventional design and formed of stainless steel or other alloys as known in the art. The radius of the ball head closely conforms to the inner cup radius of an acetabular cup liner 12 which can be mounted in cement 13 directly to the pelvis 11. Alternatively, a metallic acetabular cup can be cemented to the pelvis and the cup liner 12 can form a coating or liner connected to the cup by cement or other means as known in the art.

The specific form of the prosthesis can vary greatly as known in the art. Many hip joint constructions are known and other prostheses such as knee joints are known. All such prior art prostheses can be benefited by making at least one load bearing surface of such prosthesis of a high molecular weight polyethylene material in accordance with this invention. Such load bearing surfaces can be in the form of layers, linings or actual whole devices as shown in FIG. 1. In all cases, it is preferred that the load bearing surface act in conjunction with a metallic or ceramic mating member of the prosthesis so that a sliding surface is formed therebetween. Such sliding surfaces are subject to breakdown of the polyethylene as known in the prior art. Such breakdown can be greatly diminished by use of the materials of the present invention.

FIG. 2 shows the cup liner in the form of a half hollow ball-shaped device better seen in the cross-section of FIG. 3. As previously described, the outer surface 20 of the cup liner need not be circular or hemispherical but can be square or of any configuration to be adhered directly to the pelvis or to the pelvis through a metallic cup as known in the art. The radius of the cup liner shown at 21 in FIG. 3 of the preferred embodiment ranges from about 20 mm to about 35 mm. The thickness of the cup liner from its generally hemispherical hollow portion to the outer surface 20 is preferably about 8 mm. The outer radius is preferably in the order of about 20 mm to about 35 mm.

In some cases, the ball joint can be made of the UHMWPE of this invention and the cup formed of metal, although it is preferred to make the cup or cup liner of UHMWPE to mate with the metallic ball. The particular method of attachment of the components of the prosthesis to the bones of the body can vary greatly as known in the art.

The medical prosthesis includes, e.g., orthopedic joint and bone replacement parts, e.g., hip, knee, elbow or ankle replacements. The prosthesis can be in the form of a cup shaped article which has a load bearing surface. Medical prostheses are also meant to include any wearing surface of a prosthesis, e.g., a coating on a surface of a prosthesis in which the prosthesis is made from a material other than the UHMWPE of this invention.

The prostheses of this invention are useful for contact with metal containing parts formed of, e.g., stainless steel, titanium alloy or nickel cobalt alloy, or with ceramic containing parts. For example, a hip joint is constructed in which a cup shaped article having an inner radius of 25 mm, is contacted with a metal ball having an outer radius of 25 mm, so as to closely mate with the cup shaped article. The load bearing surface of the cup shaped article of this example is made from the UHMWPE of this invention, preferably having a thickness of at least about 1/4 inch and more preferably having a thickness of about 1/3 inch or more.

The prostheses can have any standard known form, shape, or configuration, or be a custom design, but have at least one load bearing surface of UHMWPE of this invention.

The prostheses of this invention are non-toxic to humans. They are not subject to deterioration by normal body constituents, e.g., blood or interstitial fluids. They are capable of being sterilized by standard means, including, e.g., heat or irradiation.

By UHMWPE is meant linear non-branched chains of ethylene that have molecular weights in excess of about 500,000, preferably above about 1,000,000, and more preferably above about 2,000,000. Often the molecular weights can reach about 8,000,000. By initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any irradiation.

The UHMWPE of this invention has a polymeric structure with less than about 50% crystallinity, preferably less than about 40% crystallinity, more preferably less than about 35% crystallinity, and most preferably less than about 30% crystallinity. By crystallinity is meant the fraction of the polymer that is crystalline. The crystallinity is calculated by knowing the weight of the sample (w, in g), the heat absorbed by the sample in melting (E, in cal) and the heat of melting of polyethylene crystals (.DELTA.H=69.2 cal/g), and using the following equation: ##EQU1##

The UHMWPE of this invention has a polymeric structure with less than about 290 .ANG. lamellar thickness, preferably less than about 200 .ANG. lamellar thickness, and most preferably less than about 100 .ANG. lamellar thickness. By lamellar thickness (1) is meant the calculated thickness of assumed lamellar structures in the polymer using the following expression: ##EQU2## where, .sigma..sub.e is the end free surface energy of polyethylene (2.22.times.10.sup.-6 cal/cm.sup.2), .DELTA.H is the heat of melting of polyethylene crystals (69.2 cal/g), .rho. is the density of the crystalline regions (1.005 g/cm.sup.3), T.sub.m.sup.0 is the melting point of a perfect polyethylene crystal (418.15 K) and T.sub.m is the experimentally determined melting point of the sample.

The UHMWPE of this invention has less than about 940 MPa tensile elastic modulus, preferably less than about 600 MPa tensile elastic modulus, more preferably less than about 400 MPa tensile elastic modulus, and most preferably less than about 200 MPa tensile elastic modulus. By tensile elastic modulus is meant the ratio of the nominal stress to corresponding strain for strains less than 0.5% as determined using the standard test ASTM 638 M III.

In one embodiment, the UHMWPE of this invention has a polymeric structure with about 40% crystallinity, about 100 .ANG. lamellar thickness and about 200 MPa tensile elastic modulus.

It is preferred that the UHMWPE have no trapped free radicals, especially unsaturated trans-vinylene free radicals. It is preferred that the UHMWPE have a hardness less than about 65 on the Shore D scale, more preferably a hardness less than about 55 on the Shore D scale, most preferably a hardness less than about 50 on the Shore D scale. By hardness is meant the instantaneous indentation hardness measured on the Shore D scale using a durometer described in ASTM D2240. It is preferred that the UHMWPE be substantially not oxidized and/or have substantially no chain scission. By substantially not oxidized is meant that the ratio of the area under the carbonyl peak at 1740 cm.sup.-1 in the FTIR spectra to the area under the peak at 1460 cm.sup.-1 in the FTIR spectra of the melt-irradiated sample be of the same order of magnitude as the ratio for the sample before melt irradiation. By substantially no chain scission is meant that the fraction of the polymer sample dissolving in normal xylene at 130.degree. C. and remaining in solution after cooling to room temperature be less than or equal to the fraction of the conventional UHMWPE dissolving in normal xylene at 130.degree. C. and remaining in solution after cooling to room temperature within the margins of experimental error. In some embodiments, the polymeric structure has extensive cross-linking such that a substantial portion of the polymeric structure does not dissolve in Decalin.TM. (decahydronaphthalene). By substantial portion is meant at least 50% of the polymer sample's dry weight. By not dissolve in Decalin.TM. is meant does not dissolve in Decalin.TM. at 150.degree. C. over a period of 24 hours. Preferably, the UHMWPE has a high density of entanglement so as to cause the formation of imperfect crystals and reduce crystallinity. By the density of entanglement is meant the number of points of entanglement of polymer chains in a unit volume; a higher density of entanglement being indicated by the polymer sample's inability to crystallize to the same extent as conventional UHMWPE, thus leading to a lesser degree of crystallinity.

The polymeric structure of the UHMWPE used in the prostheses of this invention results in the reduction of production of fine particles from the prosthesis during wear of the prosthesis. As a result of the limited number of fine polyethylene particles being shed into the body, the prosthesis exhibits longer implant life. Preferably, the prosthesis can remain implanted in the body for at least 10 years, more preferably for at least 20 years and most preferably for the entire lifetime of the patient.

The invention also includes other fabricated articles made from UHMWPE having a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus. Such articles include shaped articles and unshaped articles, including, e.g., machined or molded objects, e.g., cups, gears, nuts, sled runners, bolts, fasteners and the like, and bar stock, films, cylindrical bars, sheeting, panels, and fibers. Shaped articles can be made, e.g., by machining. The fabricated articles are particularly suitable for load bearing applications, e.g., as a load bearing surface, and as metal replacement articles. Thin films or sheets of UHMWPE, which have been melt-irradiated can also be attached, e.g., with glue, onto supporting surfaces, and thus used as a transparent, wear resistant load bearing surface.

The invention also includes UHMWPE which has a unique polymeric structure characterized by less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus. Depending upon the particular processing used to make the UHMWPE, certain impurities may be present in the UHMWPE of this invention, including, e.g., calcium stearate, mold release agents, extenders, anti-oxidants and/or other conventional additives to polyethylene polymers. In certain embodiments, the UHMWPE has high transmissivity of light, preferably a transmission greater than about 10% of light at 517 nm through a 1 mm thick sample, more preferably a transmission greater than about 30% of light at 517 nm through a 1 mm thick sample, and most preferably a transmission greater than about 40% of light at 517 nm through a 1 mm thick sample. Such UHMWPE is particularly useful for thin films or sheets which can be attached onto supporting surfaces of various articles, the film or sheet being transparent and wear resistant.

This invention also provides a method for making UHMWPE which is highly entangled and crosslinked. Preferably, this UHMWPE has a polymeric structure with less than about 50% crystallinity, less than about 290 .ANG. lamellar thickness and less than about 940 MPa tensile elastic modulus. Conventional UHMWPE, e.g., a powder, a bar stock, a shaped bar stock, a coating, or a fabricated article is provided. By conventional UHMWPE is meant commercially available high density (linear) polyethylene of molecular weights greater than about 500,000. Preferably, the UHMWPE starting material has an average molecular weight of greater than about 2 million. By initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any irradiation. This UHMWPE is surrounded with an inert material that is substantially free of oxygen, e.g., nitrogen, argon or helium. The UHMWPE is heated above its melting temperature for a time sufficient to allow the UHMWPE chains to take up an entangled state. Preferably, the temperature is about 145.degree. C. to about 230.degree. C., and more preferably, is about 175.degree. to about 200.degree. C. The period of time of heating should be sufficient to permit the UHMWPE polymer chains to take up a random coil conformation. Preferably, the heating is maintained so to keep the polymer at the preferred temperature for about 5 minutes to about 3 hours, and more preferably for about 30 minutes to about 2 hours. The UHMWPE is then irradiated so as to trap the polymer chains in the entangled state, e.g., with gamma irradiation or electron irradiation. In general, gamma irradiation gives a high penetration depth but takes a longer time, resulting in increased cost of operation and the possibility of some oxidation. In general, electron irradiation gives more limited penetration depths but takes a shorter time, and hence the cost and the possibility of oxidation is reduced. The irradiation dose can be varied to control the d